Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31685763 | 0.90 | P2RY1 (0.57) | P2RY1KDM4E | |
| SCHEMBL31685858 | 0.86 | PNP (0.53) | — | |
| SCHEMBL31685282 | 0.86 | KDM4E (0.63) | P2RY1KDM4ETAS1R3TAS1R1 | |
| SCHEMBL31685175 | 0.84 | P2RY1 (0.51) | P2RY1KDM4E | |
| SCHEMBL31685593 | 0.83 | TAS1R3 (0.57) | P2RY1TAS1R3TAS1R1 | |
| SCHEMBL31685518 | 0.83 | P2RY1 (0.51) | P2RY1KDM4E | |
| SCHEMBL31685754 | 0.82 | TAS1R3 (0.57) | TAS1R3TAS1R1 | |
| SCHEMBL31685476 | 0.80 | P2RY1 (0.54) | P2RY1 | |
| SCHEMBL31685346 | 0.80 | KDM4E (0.59) | P2RY1KDM4ETAS1R3TAS1R1 | |
| SCHEMBL2985702 | 0.78 | POLB (0.61) | P2RY1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | P2RY1 2249/4885KDM4E 3958/4885TAS1R3 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.